Search research articles
Contact Us
Filters
Showing results (61-70 of 105) with videos related to
Page
of 11
Sort By:
Molecular Cancer
|
June 3, 2019
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression
Peng-Fei Zhang, Chuan-Yuan Wei, Xiao-Yong Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 7, 2019
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
Rui Peng, Peng-Fei Zhang, Xuan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2013
Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma
Jie-Yi Shi, Qiang Gao, Zhi-Chao Wang, et al.
Biomarker Research
|
April 26, 2022
KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
Chao Gao, Si-Wei Wang, Jia-Cheng Lu, et al.
Hepatology (Baltimore, Md.)
|
June 26, 2010
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma
Guo-Ming Shi, Ai-Wu Ke, Jian Zhou, et al.
The Journal of Pathology
|
September 27, 2014
CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma
Jie-Yi Shi, Liu-Xiao Yang, Zhi-Chao Wang, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2008
Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma
Ai-Wu Ke, Guo-Ming Shi, Jian Zhou, et al.
Cancer Cell International
|
March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
Zheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
The Journal of Pathology
|
August 24, 2017
Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma
Li-Jie Ma, Xiao-Ying Wang, Meng Duan, et al.
Oncotarget
|
December 18, 2015
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity
Jie-Yi Shi, Qingfeng Xing, Meng Duan, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 105) with videos related to
Sort By:
Page
of 11
Molecular Cancer
|
June 3, 2019
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression
Peng-Fei Zhang, Chuan-Yuan Wei, Xiao-Yong Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 7, 2019
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
Rui Peng, Peng-Fei Zhang, Xuan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2013
Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma
Jie-Yi Shi, Qiang Gao, Zhi-Chao Wang, et al.
Biomarker Research
|
April 26, 2022
KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
Chao Gao, Si-Wei Wang, Jia-Cheng Lu, et al.
Hepatology (Baltimore, Md.)
|
June 26, 2010
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma
Guo-Ming Shi, Ai-Wu Ke, Jian Zhou, et al.
The Journal of Pathology
|
September 27, 2014
CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma
Jie-Yi Shi, Liu-Xiao Yang, Zhi-Chao Wang, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2008
Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma
Ai-Wu Ke, Guo-Ming Shi, Jian Zhou, et al.
Cancer Cell International
|
March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
Zheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
The Journal of Pathology
|
August 24, 2017
Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma
Li-Jie Ma, Xiao-Ying Wang, Meng Duan, et al.
Oncotarget
|
December 18, 2015
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity
Jie-Yi Shi, Qingfeng Xing, Meng Duan, et al.
Page
of 11